MOESM7 of Tracking longitudinal genetic changes of circulating tumor DNA (ctDNA) in advanced Lung adenocarcinoma treated with chemotherapy
Xiaohong Han
Ying Han
Qiaoyun Tan
Yu Huang
Jianliang Yang
Sheng Yang
Xiaohui He
Shengyu Zhou
Yan Song
Jinping Pi
Lijie Zuo
Jiarui Yao
Di Wu
Zhishang Zhang
Yuankai Shi
10.6084/m9.figshare.9962840.v1
https://springernature.figshare.com/articles/journal_contribution/MOESM7_of_Tracking_longitudinal_genetic_changes_of_circulating_tumor_DNA_ctDNA_in_advanced_Lung_adenocarcinoma_treated_with_chemotherapy/9962840
Additional file 7: Figure S3. Predictors of plasma VAFs during platinum-based chemotherapy. Plasma VAFs of mutant genes (A, B and C) and Gene express of ROBO2(D) between tumor and normal in TCGA cohort, and function domain altered in gene ROBO2. Each dot represented one samples. Two truncating mutations (including nonsense, nonstop, frameshift deletion, frameshift insertion and splice site) were indicated with hotpink2 dot, ***p < 0.001, **p < 0.01, *p < 0.05.
2019-10-10 08:55:21
CtDNA
Efficacy
Chemotherapy
Lung adenocarcinoma